Ginkgo Bioworks Holdings, Inc. (DNA) › Operating IncomeGinkgo Bioworks Holdings, Inc. (DNA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$71.60M2020: -$137.03M2021: -$1.83B2022: -$2.21B2023: -$864.41M2024: -$559.76M2025: -$315.28M-$315.28M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$315.28M+43.7%2024-$559.76M+35.2%2023-$864.41M+60.9%2022-$2.21B-20.8%2021-$1.83B-1234.4%2020-$137.03M-91.4%2019-$71.60M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share